Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Amlodipine enhances amelioration of vascular insulin resistance, oxidative stress, and metabolic disorders by candesartan in metabolic syndrome rats.

Sueta D, Nakamura T, Dong YF, Kataoka K, Koibuchi N, Yamamoto E, Toyama K, Yasuda O, Ogawa H, Kim-Mitsuyama S.

Am J Hypertens. 2012 Jun;25(6):704-10. doi: 10.1038/ajh.2012.26. Epub 2012 Mar 15.

PMID:
22421905
2.

Candesartan and amlodipine combination therapy provides powerful vascular protection in stroke-prone spontaneously hypertensive rats.

Takai S, Jin D, Shimosato T, Sakonjo H, Miyazaki M.

Hypertens Res. 2011 Feb;34(2):245-52. doi: 10.1038/hr.2010.224. Epub 2010 Nov 25.

PMID:
21107329
3.

Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease.

Nutahara K, Higashihara E, Horie S, Kamura K, Tsuchiya K, Mochizuki T, Hosoya T, Nakayama T, Yamamoto N, Higaki Y, Shimizu T.

Nephron Clin Pract. 2005;99(1):c18-23.

PMID:
15637459
4.

Coronary vascular dysfunction promoted by oxidative-nitrative stress in SHRSP.Z-Lepr(fa) /IzmDmcr rats with metabolic syndrome.

Kagota S, Fukushima K, Umetani K, Tada Y, Nejime N, Nakamura K, Mori H, Sugimura K, Kunitomo M, Shinozuka K.

Clin Exp Pharmacol Physiol. 2010 Nov;37(11):1035-43. doi: 10.1111/j.1440-1681.2010.05432.x.

PMID:
20659132
5.

Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.

Yu Y, Fukuda N, Yao EH, Matsumoto T, Kobayashi N, Suzuki R, Tahira Y, Ueno T, Matsumoto K.

Am J Hypertens. 2008 Jan;21(1):72-7.

PMID:
18091747
6.

Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).

Maeda A, Tamura K, Kanaoka T, Ohsawa M, Haku S, Azushima K, Dejima T, Wakui H, Yanagi M, Okano Y, Fujikawa T, Toya Y, Mizushima S, Tochikubo O, Umemura S.

Clin Exp Hypertens. 2012;34(4):249-57. doi: 10.3109/10641963.2012.681081. Epub 2012 May 9.

PMID:
22571446
7.

Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension.

Zhou MS, Schulman IH, Raij L.

Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H833-9. doi: 10.1152/ajpheart.01096.2008. Epub 2009 Jan 16.

8.

Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study).

Yamashita T, Inoue H, Okumura K, Kodama I, Aizawa Y, Atarashi H, Ohe T, Ohtsu H, Kato T, Kamakura S, Kumagai K, Kurachi Y, Koretsune Y, Saikawa T, Sakurai M, Sato T, Sugi K, Nakaya H, Hirai M, Hirayama A, Fukatani M, Mitamura H, Yamazaki T, Watanabe E, Ogawa S; J-RHYTHM II Investigators.

Europace. 2011 Apr;13(4):473-9. doi: 10.1093/europace/euq439. Epub 2010 Dec 10.

PMID:
21148662
9.

Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats.

Dong YF, Kataoka K, Tokutomi Y, Nako H, Nakamura T, Toyama K, Sueta D, Koibuchi N, Yamamoto E, Ogawa H, Kim-Mitsuyama S.

J Pharmacol Exp Ther. 2011 Nov;339(2):358-66. doi: 10.1124/jpet.111.182576. Epub 2011 Aug 1.

10.

Beneficial action of candesartan cilexetil plus amlodipine or ACE inhibitors in chronic nondiabetic renal disease.

Homma K, Hayashi K, Kanda T, Yoshioka K, Takamatsu I, Tatematsu S, Kumagai H, Wakino S, Saruta T.

J Hum Hypertens. 2004 Dec;18(12):879-84.

PMID:
15295613
12.

Effects of benidipine and candesartan on kidney and vascular function in hypertensive Dahl rats.

Yao K, Sato H, Sonoda R, Ina Y, Suzuki K, Ohno T.

Hypertens Res. 2003 Jul;26(7):569-76.

13.
14.

Effects of up-titration of candesartan versus candesartan plus amlodipine on kidney function in type 2 diabetic patients with albuminuria.

Okura T, Kojima M, Machida H, Sugiyama M, Kato T, Komada T, Miyazaki T, Ninomiya T, Ichikawa T, Nakatani K, Watanabe Y, Dohi Y, Ito M, Kimura G.

J Hum Hypertens. 2012 Apr;26(4):214-9. doi: 10.1038/jhh.2011.22. Epub 2011 Mar 17.

PMID:
21412266
15.

Critical role of angiotensin II in excess salt-induced brain oxidative stress of stroke-prone spontaneously hypertensive rats.

Kim-Mitsuyama S, Yamamoto E, Tanaka T, Zhan Y, Izumi Y, Izumiya Y, Ioroi T, Wanibuchi H, Iwao H.

Stroke. 2005 May;36(5):1083-8. Epub 2005 Apr 7.

16.

Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome.

Kishi T, Hirooka Y, Konno S, Sunagawa K.

J Hypertens. 2012 Aug;30(8):1646-55. doi: 10.1097/HJH.0b013e328355860e.

PMID:
22728908
17.

ARB candesartan and CCB amlodipine in hypertensive patients: the CASE-J trial.

Ogihara T, Fujimoto A, Nakao K, Saruta T; CASE-J Trial Group.

Expert Rev Cardiovasc Ther. 2008 Oct;6(9):1195-201. doi: 10.1586/14779072.6.9.1195.

PMID:
18939907
18.

Peroxynitrite is Involved in the dysfunction of vasorelaxation in SHR/NDmcr-cp rats, spontaneously hypertensive obese rats.

Kagota S, Tada Y, Kubota Y, Nejime N, Yamaguchi Y, Nakamura K, Kunitomo M, Shinozuka K.

J Cardiovasc Pharmacol. 2007 Dec;50(6):677-85.

PMID:
18091585
19.

Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice.

Suzuki J, Iwai M, Li Z, Li JM, Min LJ, Ide A, Yoshii T, Oshita A, Mogi M, Horiuchi M.

J Hypertens. 2005 Jul;23(7):1383-9.

PMID:
15942461
20.

Nifedipine enhances the cardioprotective effect of an angiotensin-II receptor blocker in an experimental animal model of heart failure.

Okuda N, Hayashi T, Mori T, Inamoto S, Okabe M, Mieno S, Horimoto H, Kitaura Y.

Hypertens Res. 2005 May;28(5):431-8.

PMID:
16156507

Supplemental Content

Support Center